Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BerGenBio Director's Dealing 2022

Jan 7, 2022

3555_dirs_2022-01-07_255bcfbf-5079-4336-865e-134f139999eb.html

Director's Dealing

Open in viewer

Opens in your device viewer

BERGENBIO - Mandatory notification of trade by Primary Insider

BERGENBIO - Mandatory notification of trade by Primary Insider

Bergen, Norway,7 January 2022?-BerGenBioASA (OSE: BGBIO) (the "Company"), has

been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has

bought 10,000 shares in BerGenBio ASA at an average price of NOK 20.03 per

share. After the transaction Mr. Olin holds 18,000 shares in BerGenBio ASA.

Please see the attached document for further details of the transaction.

Contact:

[email protected]

RuneSkeie, CFO,BerGenBioASA

[email protected]

This information issubject to the disclosure requirements pursuant to the EU

Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities

Trading Act.